Associated Papers
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial.
Hoyer K et al.
Ebiomedicine, 2021
33862582 (PubMed )
Supplement: mmc3.xlsx › S5
Structural Analysis of the Bacterial Effector AvrA Identifies a Critical Helix Involved in Substrate Recognition.
Labriola JM et al.
Biochemistry, 2018
Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells.
Cazillis M et al.
Oncogene, 2004
Select a paper to view details